- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Q&A with George Barrett: Cardinal Health’s commitment to independent pharmacy
- Helping independents compete in specialty pharmacy, Cardinal Health launches new suite of services at RBC 2013
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- Walgreens Infusion Services can save $10.8 million in healthcare costs annually
Goodbye to a friend of pharmacy.
In this case, we’re not talking about an individual; we’re talking about a fledgling company called RxAlly, and about its grand but ultimately unsuccessful plan to combine the collective strengths of thousands of pharmacies to advance a higher and more engaged form of pharmacy practice. So, as much as anything, we’re saying goodbye to an idea.
It was a good idea. RxAlly got up and running some 18 months ago with a noble vision: to bring together “an unprecedented alliance of pharmacies united to help patients achieve better health through personalized pharmacist care while reducing costs,” in the words of its leaders.
For a while, it did just that. At its peak before announcing last week that it was shuttering its operations, RxAlly had signed up a national network of more than 22,000 chain and independent pharmacies working to advance patient-care services and cost-effective solutions for patients and health plan payers.
What’s more, it was led by a couple of retail pharmacy thoroughbreds: CEO Bruce Roberts, who emerged as independent pharmacy’s most articulate and visible defender in his years as head of the National Community Pharmacists Association; and Rebecca Chater, who served as one of chain pharmacy’s top visionaries and champions on behalf of a higher form of pharmacy practice and patient care in her years as head of clinical services for Raleigh, N.C.-based Kerr Drug. Chater joined RxAlly in late 2012 as VP-health outcomes.
Announcing its board’s decision to shutter the operation, RxAlly said Friday it was “disappointed in this outcome,” but mindful of “the progress we made in developing a shared interest in advancing pharmacist care.” And there was progress, including supporting pilot projects to boost patient adherence and the release of a white paper in May, “Personalized Pharmacist Care: Healing America's Post-Reform Health Care System,” that fleshes out the concept of “individually tailored, pharmacist-provided clinical and consultative services to improve patient quality of life and optimize clinical and economic outcomes” as a solution to America’s overwrought and overstretched health system.
The closing of RxAlly is a disappointment to some advocates of a higher form of pharmacy practice, but it doesn’t signal any retreat by the profession or the retail pharmacy industry from their long campaign to elevate pharmacy’s place in the U.S. health system and engage more directly with patient outcomes and cost-effective care solutions.
What’s your take on the closing of this 18-month effort to weld together a national force for advancing pharmacy-based clinical care? Is it a real defeat or just a setback on pharmacy’s road to a new and higher level of practice and patient engagement?
Are you a nurse practitioner or physician's assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.